SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is under pressure amid reports about CEO Jensen Huangs relationship with a woman described as a suspected Chinese spy and scrutiny over whether chips reached China in breach of export restrictions, raising governance, national-security and leadership concerns. Bulls argue the selloff overstates the risk and point to continued AI demand and CoreWeaves strong results, while skeptics see uncertainty around the investigation and Huangs role as an overhang.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves quarterly revenue beat and raised outlook, alongside strong AI-cloud demand, have fueled a relief rally and short-squeeze speculation. Bulls say customer prepayments and secured financing ease funding concerns, while skeptics argue heavy debt, interest costs and capital spending still cloud the path to sustainable profitability.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is drawing attention ahead of its Q3 earnings report, with traders focused on whether Northern Datas AI data-center revenue and the Quake AI expansion can drive a strong result; bullish posts also point to the Anthropic agreement and elevated short interest as potential catalysts. Others question financing, dilution and execution, and some dispute how much the reported contract will translate into revenue.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists quarterly results and earnings call are driving attention, with traders weighing improved profitability and recurring Samsung and Micron licensing revenue against a miss versus elevated expectations and weaker product sales. Many are bullish on managements stronger outlook and speculate that SK Hynix could be the next licensing partner, though no new Hynix deal was confirmed.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis quarterly results missed expectations and its revenue outlook disappointed, fueling concerns about its valuation and how long quantum computing commercialization may take. Bears question the companys limited near-term business traction, while bullish traders point to technical progress, cash reserves and government support as reasons to focus on the longer-term opportunity.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,959,453.18587388 with 16,959,453.64420722 in circulation. The last known price of Zcash is 1,033.61575403 USD and is down -11.66 over the last 24 hours. It is currently trading on 670 active market(s) with $1,322,935,861.71 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcash is drawing attention after a sharp selloff, with traders debating whether the drop reflects broader crypto-market weakness and liquidations or a ZEC-specific unwind. Reactions are split between dip-buyers expecting a rebound and bearish traders warning that support has broken and further losses may follow.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Bridgewater, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotechs post-earnings selloff centers on flat U.S. CARVYKTI sales and managements warning that near-term sales expectations may be too optimistic, amid slower uptake in earlier treatment lines and delayed launches overseas. Traders are split between viewing the outlook as a setback and arguing that international growth and continued global sales gains make the market reaction excessive.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

ABTCs steep post-reverse-split decline has traders focused on dilution concerns, possible further share issuance or another reverse split, and heavy short positioning; claims that these pressures are driving the selloff remain community speculation. Some investors expect a rebound alongside Bitcoin or a short squeeze, while others say the stock has lagged Bitcoin and see more downside risk.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

The FDA accepted Celcuitys supplemental application to expand REVTORPYK into PIK3CA-mutant breast cancer, with a June 2027 decision date. Traders are highlighting the cohorts clinical results and potential label expansion, while others remain focused on commercial execution and the lack of demonstrated revenue amid the stocks weakness.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with management reaffirming confidence and the application in final review ahead of the Nov. 22 action date. Traders are broadly hopeful about approval, citing the HOPE-3 upper-limb results and launch preparations, while others emphasize the binary CRL risk and uncertainty over label scope after the earlier advisory-panel vote on cardiac data.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acme United Corporation. (ACU) Surpasses Q3 Earnings and Revenue Estimates

Acme United (ACU) delivered earnings and revenue surprises of +12.68% and +4.15%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Are Consumer Discretionary Stocks Lagging  Acme United (ACU) This Year?

Here is how Acme United Corporation. (ACU) and ASICS Corporation Unsponsored ADR (ASCCY) have performed compared to their sector so far this year.

Cintas (CTAS) Q1 Earnings and Revenues Surpass Estimates

Cintas (CTAS) delivered earnings and revenue surprises of +2.96% and +1.58%, respectively, for the quarter ended August 2026. Do the numbers hold clues to what lies ahead for the stock?

Is Acme United (ACU) Stock Outpacing Its Consumer Discretionary Peers This Year?

Zacks.com featured highlights include Polaris, Intrepid Potash, Interface, NetScout Systems and Acme United 

Strong efficiency metrics and earnings surprises put Polaris, Intrepid Potash, Interface, NetScout Systems and Acme United in focus.

5 High-Efficient Stocks With Strong Financial Performance

Five stocks stand out after screening for strong efficiency metrics, including Polaris, Intrepid Potash, Interface, NetScout Systems and Acme United.

Is Acme United (ACU) a Solid Growth Stock? 3 Reasons to Think "Yes"

Acme United (ACU) possesses solid growth attributes, which could help it handily outperform the market.

Is Acme United (ACU) Outperforming Other Consumer Discretionary Stocks This Year?

Here's Why You Should Retain Westlake Stock in Your Portfolio 

WLK's HIP growth and acquisitions support its portfolio, but housing weakness, operational risks and global pressures cloud the outlook. 

Acme United (ACU) is an Incredible Growth Stock: 3 Reasons Why 

Acme United expects annual savings from the DMT closure to be more than $1M in 2027; quantified revenue, margin, and earnings guidance was not provided.

Acme United's My Medic earnings contribution was minimal amid seasonality, transportation and raw-material costs are increasing alongside DMT closure charges, and tariff-policy and supply-chain disruptions are identified risks.

Acme United posted 18% Q3 sales growth and 10% comparable growth, gross margin remained above prior-year levels excluding specified items, and My Medic integration is progressing on plan with commitments.

Acme United Corp. is engaged in the supply of cutting devices, measuring instruments, and safety products for school, home, office, hardware and industrial use. The firm offers its products under the brands First Aid Only, PhysiciansCare, Pac-Kit, Spill Magic, First Aid Central, Med-Nap, Safety Made, Elite, My Medic, Westcott, Clauss, and DMT. It operates through the following geographical segments: United States, Canada, and Europe. The company was founded in 1867 and is headquartered in Shelton, CT.

Acme United Corp.

Neutral Sentiment

Yes, by year-end

Yes, but not this year

No, he stays as CEO

He steps down on his own

Do you think Jensen Huang will be removed as Nvidia’s ($NVDA) CEO?

Stocktwits

Do you think Jensen Huang will be removed as Nvidia’s (

Stocktwits Polls

$ACU Q3 '26 Earnings Results & Recap

Acme United expects annual savings from the DMT closure to be more than $1M in 2027; quantified revenue, margin, and earnings guidance was not provided.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ACU Acme United Corp.

Fundamentals

Latest ACU News